Discovery of novel 2-aryl-4-bis-amide imidazoles (ABAI) as anti-inflammatory agents for the treatment of inflammatory bowel diseases (IBD)

Radhakrishnan, 2021, P663 Long-term follow up in IBD: 10-year observational study of a UK IBD cohort, J. Crohn's Colitis, 15, S588, 10.1093/ecco-jcc/jjab076.783 Kaplan, 2015, The global burden of IBD: from 2015 to 2025, Nat. Rev. Gastroenterol., 12, 720, 10.1038/nrgastro.2015.150 Sartor, 2006, Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis, Nat. Clin. Pract. Gastroenterol., 3, 390, 10.1038/ncpgasthep0528 Bai, 2020, Discovery of small-molecule candidates against inflammatory bowel disease, Eur. J. Med. Chem., 185, 10.1016/j.ejmech.2019.111805 Chen, 2012, Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents, J. Med. Chem., 55, 7285, 10.1021/jm300564b Zhang, 2018, Discovery of novel small-molecule inhibitors of NF-κB signaling with antiinflammatory and anticancer properties, J. Med. Chem., 61, 5881, 10.1021/acs.jmedchem.7b01557 Chen, 2021, Discovery of novel 3-hydroxyandrosta-5, 7-Diene-17-Carboxylic acid derivatives as anti-inflammatory bowel diseases (IBD) agents, Eur. J. Med. Chem., 220, 10.1016/j.ejmech.2021.113468 Curreli, 2017, Synthesis, antiviral potency, in vitro ADMET, and X-ray structure of potent CD4 mimics as entry inhibitors that target the Phe43 cavity of HIV-1 gp120, J. Med. Chem., 60, 3124, 10.1021/acs.jmedchem.7b00179 Li, 2005, Diethyldithiocarbamate inhibits iNOS expression in human lens epithelial cells stimulated by IFN-gamma and LPS, Acta Pharmacol. Sin., 26, 359, 10.1111/j.1745-7254.2005.00041.x Loppnow, 1989, Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1, Cell. Immunol., 122, 493, 10.1016/0008-8749(89)90095-6 Silva, 2018, Lipopolysaccharide and lipotheicoic acid differentially modulate epididymal cytokine and chemokine profiles and sperm parameters in experimental acute epididymitis, Sci. Rep., 8, 1 Dai, 2021, Development of novel tetrahydroquinoline inhibitors of NLRP3 inflammasome for potential treatment of DSS-induced mouse colitis, J. Med. Chem., 64, 871, 10.1021/acs.jmedchem.0c01924 Yang, 2018, Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract, Cell Death Dis., 9, 1 Kadayat, 2017, Discovery and structure-activity relationship studies of 2-benzylidene-2, 3-dihydro-1H-inden-1-one and benzofuran-3 (2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease, Eur. J. Med. Chem., 137, 575, 10.1016/j.ejmech.2017.06.018 Patil, 2019, Animal models of inflammation for screening of anti-inflammatory drugs: Implications for the discovery and development of phytopharmaceuticals, Int. J. Mol. Sci., 20, 4367, 10.3390/ijms20184367